Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 3/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | UPP1 | Q16831 | 1/20 | 0.32 |
| ▸ | WEE1 | P30291 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17045725 | 0.76 | PARP1 (0.58) | CHEK1MCL1WEE1CA1CA2 | |
| SCHEMBL13606638 | 0.76 | NPSR1 (0.54) | CHEK1MCL1WEE1CA1CA2 | |
| SCHEMBL13606626 | 0.73 | NPSR1 (0.40) | CHEK1WEE1PARP1 | |
| SCHEMBL13606492 | 0.71 | GSK3B (0.38) | CHEK1WEE1 | |
| SCHEMBL3852142 | 0.70 | PARP1 (0.63) | CHEK1MCL1WEE1CA1CA2 | |
| SCHEMBL13606625 | 0.70 | PARP1 (0.35) | CHEK1PARP1 | |
| SCHEMBL13606486 | 0.70 | GSK3B (0.37) | CHEK1WEE1 | |
| SCHEMBL11518277 | 0.70 | PARP1 (0.43) | CHEK1WEE1CA1CA2PARP1 | |
| SCHEMBL29441220 | 0.70 | PARP1 (0.43) | CHEK1WEE1CA1CA2PARP1 | |
| SCHEMBL17226269 | 0.67 | PIM1 (0.46) | MCL1UPP1PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009144205-A1 | RYLENE-BASED SEMICONDUCTOR MATERIALS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2009-12-03 | — | — | WO | disclosed |